← Back to headlines
Heron Therapeutics Reports Mixed Q4 Results and FY26 Outlook
Heron Therapeutics has released its fourth-quarter financial results, which were mixed, and also provided its financial outlook for fiscal year 2026.
26 Feb, 13:05 — 26 Feb, 13:05
ℹOnly 1 source covers this story
